{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:59:41Z","timestamp":1790740781610,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejca.2026.117075","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:42:43Z","timestamp":1790350963000},"page":"117075","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Liquid biopsy tumour fraction, total tumour volume, and automated whole-body CT body composition for survival stratification in metastatic cancer: A temporally validated pan-cancer cohort study"],"prefix":"10.1016","volume":"248","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3869-3936","authenticated-orcid":false,"given":"Aur\u00e9lie","family":"Choucair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2694-926X","authenticated-orcid":false,"given":"Jules","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Italiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghina","family":"Jardali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lama","family":"Dawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0838-2053","authenticated-orcid":false,"given":"Littisha","family":"Lawrance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Goldschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samy","family":"Ammari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6295-6361","authenticated-orcid":false,"given":"Isabelle","family":"Borget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7679-6197","authenticated-orcid":false,"given":"Paul-Henry","family":"Courn\u00e8de","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Besse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Balleyguier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Barlesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5505-0564","authenticated-orcid":false,"given":"Christophe","family":"Massard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Cromb\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Lassau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2026.117075_bib1","doi-asserted-by":"crossref","first-page":"6603","DOI":"10.1245\/s10434-023-13746-3","article-title":"The usefulness of total tumour volume as a prognostic factor and in selecting the optimal treatment strategy of chemotherapeutic intervention in patients with colorectal liver metastases","volume":"30","author":"Shimura","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2026.117075_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005092","article-title":"Imaging endpoints for clinical trial use: a RECIST perspective","volume":"10","author":"Liti\u00e8re","year":"2022","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ejca.2026.117075_bib3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jamaoncol.2021.6818","article-title":"Early readout on overall survival of patients with melanoma treated with immunotherapy using a novel imaging analysis","volume":"8","author":"Dercle","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejca.2026.117075_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237802","article-title":"Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin","volume":"15","author":"Woodhouse","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ejca.2026.117075_bib5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41698-024-00685-9","article-title":"Tumour fraction-based prognostic tool for cancer patients referred to early phase clinical trials","volume":"8","author":"Bayle","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.ejca.2026.117075_bib6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13045-022-01351-y","article-title":"Liquid biopsy: current technology and clinical applications","volume":"15","author":"Nikanjam","year":"2022","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.ejca.2026.117075_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.annonc.2022.09.163","article-title":"Prognostic value of plasma circulating tumour DNA fraction across four common cancer types: a real-world outcomes study","volume":"34","author":"Reichert","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2026.117075_bib8","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.232674","article-title":"Liquid biopsy versus CT: comparison of tumour burden quantification in 1065 patients with metastases","volume":"313","author":"Dawi","year":"2024","journal-title":"Radiology"},{"key":"10.1016\/j.ejca.2026.117075_bib9","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.diii.2025.06.002","article-title":"Baseline CT-derived tumour burden and liquid biopsy as biomarkers to predict survival in patients with metastatic solid cancer","volume":"106","author":"Jardali","year":"2025","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.ejca.2026.117075_bib10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: mediators, signalling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.ejca.2026.117075_bib11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pharmthera.2018.12.003","article-title":"Body composition and sarcopenia: the next-generation of personalized oncology and pharmacology?","volume":"196","author":"Hilmi","year":"2019","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ejca.2026.117075_bib12","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.3390\/nu15051193","article-title":"Pre-therapeutic sarcopenia among cancer patients: an up-to-date meta-analysis of prevalence and predictive value during cancer treatment","volume":"15","author":"Couderc","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.ejca.2026.117075_bib13","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/TP.0b013e31827a0f27","article-title":"Objective radiologic assessment of body composition in patients with end-stage liver disease: going beyond the BMI","volume":"95","author":"Cruz","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.ejca.2026.117075_bib14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10278-019-00178-3","article-title":"Anthropometer3D: automatic multi-slice segmentation software for the measurement of anthropometric parameters from CT of PET\/CT","volume":"32","author":"Decazes","year":"2019","journal-title":"J Digit Imaging"},{"key":"10.1016\/j.ejca.2026.117075_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007315","article-title":"Synergic prognostic value of 3D CT scan subcutaneous fat and muscle masses for immunotherapy-treated cancer","volume":"11","author":"Decazes","year":"2023","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ejca.2026.117075_bib16","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/M14-0698","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration","volume":"162","author":"Moons","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejca.2026.117075_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.114020","article-title":"Imaging-guided prognostic score-based approach to assess the benefits of combotherapy versus monotherapy with immune checkpoint inhibitors in metastatic MSI-H colorectal cancer patients","volume":"202","author":"Barbe","year":"2024","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2026.117075_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.982790","article-title":"Predicting immunotherapy outcomes in patients with MSI tumors using NLR and CT global tumour volume","volume":"12","author":"Belkouchi","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejca.2026.117075_bib19","unstructured":"Roche Diagnostics. FoundationOne Liquid CDx [Internet]. Available from: https:\/\/diagnostics.roche.com."},{"key":"10.1016\/j.ejca.2026.117075_bib20","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41416-020-01047-5","article-title":"Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond","volume":"124","author":"Keller","year":"2021","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2026.117075_bib21","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.mednuc.2018.03.027","article-title":"\u00c9valuation d\u2019Anthropometer 3D, logiciel d\u2019extraction automatique de multiples param\u00e8tres anthropom\u00e9triques \u00e0 partir des TEP\/TDM","volume":"42","author":"Tonnelet","year":"2018","journal-title":"M\u00e9decine Nucl"},{"key":"10.1016\/j.ejca.2026.117075_bib22","first-page":"205","article-title":"Body composition to define prognosis of cancers treated by anti-angiogenic drugs","volume":"13","author":"Decazes","year":"2023","journal-title":"Diagn (Basel)"},{"key":"10.1016\/j.ejca.2026.117075_bib23","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1214\/08-AOAS169","article-title":"Random survival forests","volume":"2","author":"Ishwaran","year":"2008","journal-title":"Ann Appl Stat"},{"key":"10.1016\/j.ejca.2026.117075_bib24","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/sim.4154","article-title":"On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data","volume":"30","author":"Uno","year":"2011","journal-title":"Stat Med"},{"key":"10.1016\/j.ejca.2026.117075_bib25","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1002\/(SICI)1097-0258(19990915\/30)18:17\/18<2529::AID-SIM274>3.0.CO;2-5","article-title":"Assessment and comparison of prognostic classification schemes for survival data","volume":"18","author":"Graf","year":"1999","journal-title":"Stat Med"},{"key":"10.1016\/j.ejca.2026.117075_bib26","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1177\/0962280213515571","article-title":"Summary measure of discrimination in survival models based on cumulative\/dynamic time-dependent ROC curves","volume":"25","author":"Lambert","year":"2016","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.ejca.2026.117075_bib27","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s13244-015-0414-0","article-title":"Imaging body composition in cancer patients: visceral obesity, sarcopenia and sarcopenic obesity may impact on clinical outcome","volume":"6","author":"Yip","year":"2015","journal-title":"Insights Imaging"},{"key":"10.1016\/j.ejca.2026.117075_bib28","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1634\/theoncologist.2016-0066","article-title":"The prevalence and prognostic value of low muscle mass in cancer patients: a review of the literature","volume":"21","author":"Rier","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.ejca.2026.117075_bib29","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/jcsm.12379","article-title":"The evolution of body composition in oncology\u2014epidemiology, clinical trials, and the future of patient care: facts and numbers","volume":"9","author":"Brown","year":"2018","journal-title":"J Cachex-- Sarcopenia Muscle"},{"key":"10.1016\/j.ejca.2026.117075_bib30","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1186\/s12885-017-3480-5","article-title":"Prognostic value of total tumor volume in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy","volume":"17","author":"Liang","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejca.2026.117075_bib31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.amsu.2020.04.001","article-title":"Total tumor volume as a prognostic value for survival following liver resection in patients with hepatocellular carcinoma. Retrospective cohort study","volume":"54","author":"Zakaria","year":"2020","journal-title":"Ann Med Surg (Lond)"},{"key":"10.1016\/j.ejca.2026.117075_bib32","article-title":"Total tumor volume predicts overall survival and response to induction chemotherapy in patients with colorectal cancer liver metastases: an ancillary study of the phase 3 CAIRO5 trial","volume":"228","author":"Zeeuw","year":"2025","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2026.117075_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrai.2026.100078","article-title":"Delta total tumor volume and radiomics as predictive biomarkers in microsatellite instability-high metastatic colorectal cancer","volume":"6","author":"Dupont","year":"2026","journal-title":"Eur J Radiol Artif Intell"},{"key":"10.1016\/j.ejca.2026.117075_bib34","article-title":"Prognostic value of sarcopenia in patients with rectal cancer: a meta-analysis","volume":"17","author":"Zhu","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ejca.2026.117075_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2023.106608","article-title":"Association of sarcopenia with oncologic outcomes of primary treatment among patients with oral cavity cancer: a systematic review and meta-analysis","volume":"147","author":"Graves","year":"2023","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ejca.2026.117075_bib36","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.gene.2018.09.029","article-title":"Prognostic value of circulating cell-free DNA in patients with pancreatic cancer: a systematic review and meta-analysis","volume":"679","author":"Chen","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.ejca.2026.117075_bib37","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/ijc.32586","article-title":"Circulating tumour DNA quantity is related to tumour volume and both predict survival in metastatic pancreatic ductal adenocarcinoma","volume":"146","author":"Strijker","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2026.117075_bib38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13073-020-00723-8","article-title":"Comprehensive characterization of cell-free tumour DNA in plasma and urine of patients with renal tumours","volume":"12","author":"Smith","year":"2020","journal-title":"Genome Med"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926008579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926008579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:24:42Z","timestamp":1790738682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804926008579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":38,"alternative-id":["S0959804926008579"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2026.117075","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liquid biopsy tumour fraction, total tumour volume, and automated whole-body CT body composition for survival stratification in metastatic cancer: A temporally validated pan-cancer cohort study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2026.117075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117075"}}